Human chromosome 11p15.5 and distal mouse chromosome 7 include a megabase-scale chromosomal domain with multiple genes subject to parental imprinting. Here we describe mouse and human versions of a novel imprinted gene, IMPT1, which lies between IPL and p57 KIP2 and which encodes a predicted multi-membrane-spanning protein similar to bacterial and eukaryotic polyspecific metabolite transporter and multi-drug resistance pumps. Mouse Impt1 and human IMPT1 mRNAs are highly expressed in tissues with metabolite transport functions, including liver, kidney, intestine, extra-embryonic membranes and placenta, and there is strongly preferential expression of the maternal allele in various mouse tissues at fetal stages. In post-natal tissues there is persistent expression, but the allelic bias attenuates. An allelic expression bias is also observed in human fetal and postnatal tissues, but there is significant interindividual variation and rare somatic allele switching. The fact that Impt1 is relatively repressed on the paternal allele, together with data from other imprinted genes, allows a statistical conclusion that the primary effect of human chromosome 11p15.5/mouse distal chromosome 7 imprinting is domainwide relative repression of genes on the paternal homolog. Dosage regulation of the metabolite transporter gene(s) by imprinting might regulate placental and fetal growth.
INTRODUCTION
Seven years have elapsed since the discovery of endogenous imprinted genes and the subsequent demonstration of conservation of imprinting between mice and humans, but we still do not have a coherent understanding of the mechanism and biological rationale of this phenomenon. Progress has been hampered not by the lack of a theoretical framework (1) (2) (3) (4) , but rather by the paucity of examples of imprinted genes. This situation is slowly changing, in part because of the realization that imprinting is regional and that chromosome walking can be an effective way to identify additional imprinted genes. A megabase-scale region on chromosome 11p15.5 in humans and the corresponding area of distal chromosome 7 in mice have been previously shown to contain at least seven imprinted genes: IGF2, H19, Ins-2, Mash-2/ASCL2, p57 KIP2 , KvLQT1 and IPL (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . A subset of these genes regulate fetal and/or placental growth and the H19, IGF2 and p57KIP2 genes show dysregulated expression and, in the case of H19, pathological biallelic hypermethylation in human embryonal tumors (reviewed in 18). Here we describe the identification, structural characterization and allelic expression analysis of mouse and human versions of a novel imprinted gene, IMPT1 (imprinted multi-membrane-spanning polyspecific transporter-like gene 1), located in this chromosomal domain between IPL and p57 KIP2 . This gene encodes a predicted protein with multiple membrane spanning segments which belongs to the polyspecific transporter/multi-drug resistance gene family. We discuss these findings in the context of current theories of the mechanism and biological/evolutionary basis of imprinting.
RESULTS

Cloning and sequence analysis of human IMPT1 and mouse Impt1
A map of the chromosome 11p15.5 imprinted region is shown in Figure 1A . Exon trapping of a P1 clone (P1-12766), which also contained the p57 KIP2 and IPL genes, yielded 227 and 150 bp putative exons with regions of identity to a contig of several human ESTs in the sequence database. The 150 bp trapped exon *To whom correspondence should be addressed. Tel: +1 212 305 1287; Fax: +1 212 305 5498; Email: bt12@columbia.edu + Present address: Department of Surgery, Division of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA § The first two authors contributed equally to this work Figure 1 . Maps of the mouse and human IMPT1 genes and PCR strategies for assessing imprinting. (A) Location of human IMPT1 relative to other chromosome 11p15.5 genes. A complete P1 clone contig spanning the illustrated region has recently been described (42) and the distances and gene order are also consistent with the estimated sizes and hybridization patterns of P1 clones in our unpublished contig spanning this region. Genes which are imprinted in either mice or humans are indicated in bold and the parental origin of the active allele is indicated above each gene. Genes which have not shown an allelic expression bias in tissues examined to date (43) (44) (45) are in plain type. The two genes in parentheses are also under study for imprinting and show allelic expression bias in some tissues (N.Qian, L.Yuan, C.Walsh, B.Tycko, unpublished observations). The 2G3-8 gene is defined by human ESTs with accession nos R07294 and N35348. m, maternal; p, paternal. (B) Size, exon/intron structure, transcriptional orientation and proximity to IPL of human IMPT1 and transcriptional orientation and proximity to Ipl of mouse Impt1. The PCR strategies for allelic expression analysis are shown under the maps; genomic PCR products (short lines immediately below the map) were contained within single exons, while the RT-PCR products (indicated as spliced segments below the genomic products) spanned exon/exon junctions. Exon/intron boundaries were sequenced in the 3 kb region of mouse Impt1 which was used for the PCR analysis and the region between the last Impt1 exon and the Ipl gene was sequenced. The exon/intron structure of the remainder of the mouse gene has not been characterized. Filled boxes are translated regions and empty boxes are 5′-and 3′-untranslated regions; ticks indicate the 3′-end of each gene. X, XbaI; N, NotI.
probe, which subsequently proved to be an illegitimately spliced product with 100 bp overlap with exon 8 of IMPT1, identified a major transcript of ∼1.5 kb on northern blots of poly(A) + RNA from human tissues ( Fig. 2A) . We next screened a human placental cDNA library with a longer probe from a cognate Image Consortium cDNA clone (clone 161372; GenBank accession no. H25503) and isolated a 1520 bp cDNA clone (clone 1G2-5-8). When applied as a northern blot probe this clone hybridized to the same major 1.5 kb transcript and also revealed several alternatively sized transcripts (Fig. 2A) . The sequence of this clone (accession no. AF028738) yielded an open translational reading frame of 408 amino acids, which was confirmed by reference to the cognate ESTs and subsequently by comparison with the sequence of the murine Impt1 cDNA (below). The 1.5 kb IMPT1 cDNA sequence included a poly(A) addition signal at the 3′-end and a reasonable, but not perfect, Kozak consensus initiation methionine codon (aggATGa) located 242 bp from the 5′-end. An unusual aspect was an in-frame ATG in a non-Kozak consensus context 45 bp upstream, a feature which was also seen in the murine cDNA (below). We have not excluded the presence of additional 5′ IMPT1 exons, but an attempt at 5′ extension by PCR of total adapter-ligated liver cDNAs (5′ RACE) did not yield clones extending beyond the 5′-end of the 1.5 kb cDNA clone.
The predicted IMPT1 protein identified many similar proteins in a Blastp analysis: all were members of a well-established family of membrane proteins with multiple membrane-spanning segments and with known or suspected polyspecific transport capabilities for small organic molecules. This family includes proteins which have been identified and studied as drug efflux pumps in bacteria (19,20; and references therein), such as the multi-drug resistance protein of Bacillus subtilis (accession no. P33449), the NapC protein of Escherichia hirae (accession no. e328773) and the tetracycline transporter of Escherichia coli (accession no. Q07282), as well as certain mammalian proteins which matched with very low probability scores in the initial Blastp screen but which showed conserved regions when analyzed directly versus IMPT1 protein using the Block Maker algorithm (Internet address http://www.blocks.fhcrc.org/blockmkr; 21), such as NKT (U52842), which has been studied as a candidate organic metabolite transporter in kidney (22) . The match with the strongest probability score (4.7e -12) was to a predicted Caenorhabditis elegans gene, C53B4.3 (accession no. 1122783), which has not yet been studied functionally; other probability scores fell in what would normally be considered a low range of 1e -7 to 0.05, but this reflects the fact that this family of proteins is recognized not only by amino acid identities and similarities but Probes and size markers are indicated. The blots with the IMPT1 probes were exposed for 3 days and the blots with the β-actin control probes were exposed for 3 h. (B) Northern blots of total RNAs from fetal (14.5 d.p.c.) and adult mouse tissues and poly(A) + RNAs from adult mouse tissues. Probes and size markers are indicated. Ethidium bromide (EtBr) staining is shown as a loading control for the total RNA blots. The blots hybridized with an Impt1 cDNA probe, a 1143 bp RT-PCR product from adult mouse liver RNA spanning the second to last exon, were exposed for 2 days and the blot hybridized with a β-actin probe was exposed for 2 h. Ki, kidney; Li, liver; Lu, lung; Br, brain; Pa, pancreas; Skm, skeletal muscle; Pl, placenta; Ht, heart; In, intestine; Th, thymus; Te, testis; EM, extra-embryonic membranes; Lm, limb; Aki, adult kidney.
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also by membrane topology and hydropathy patterns. Alignment of the human IMPT1 protein with the bacterial NapC protein (Fig. 3A) supported the proposed start codon, as the two proteins were in good register throughout their lengths, with 23.5% identical amino acids and with numerous similar amino acids, both in hydrophobic segments and in charged regions; the C.elegans protein was smaller, as were some other bacterial efflux pumps (Fig. 3B and data not shown) . Analysis with the TMpred algorithm (Internet address http://ulrec3.unil.ch/software/ TMPRED_form.html; 23) yielded a strongly preferred model which placed the N-terminus inside the cell and predicted 10 strong transmembrane helices. Alignment of the Kyte-Doolittle hydropathy plot of the human IMPT1 protein with selected other polyspecific transporter family members is shown in Figure 3B . Good alignment of the predicted transmembrane helices of the various proteins supports the assignment of IMPT1 to this gene family.
We next identified the murine ortholog of IMPT1 by screening the mouse EST database with the human IMPT1 cDNA sequence. Complete re-sequencing of two overlapping mouse cDNAs spanning 1.46 kb (clone accession nos. W71351 and AA122896) yielded an open reading frame of 406 amino acids, which aligned well with the predicted human protein throughout its length and which showed 77% overall sequence identity to the human IMPT1 protein (Fig. 3C) . Essentially, as was found for the human protein, the murine Impt1 protein was predicted to initiate from a Kozak consensus methionine codon (agcATGg), which was 9 bp downstream of an in-frame ATG embedded in a poor initiating context.
Genomic structure of IMPT1 and conserved synteny of
IMPT1-IPL in human and mouse
After our exon trapping and cDNA cloning was completed an extended block of as yet unannotated genomic sequence for the region of human chromosome 11p15.5 containing IMPT1 was deposited in GenBank (human 244 kb contig from chromosome 11p15.5, HTGS phase 3, complete sequence; accession no. U90582). By searching this sequence with the IMPT1 cDNA, the IMPT1 gene was found to consist of at least 11 exons distributed over 23 kb of DNA (Fig. 1B) . IMPT1 and IPL are transcribed towards each other in a tail-to-tail configuration and the 3′-ends of these genes are separated by 3 kb (Fig. 1B) . By mapping in an interspecific back-cross panel we previously showed that the mouse and human IPL genes are both in the region of conserved synteny spanning the known human chromosome 11p15.5/distal mouse chromosome 7 imprinted domain (17) . To test possible conserved synteny of Impt1-Ipl we isolated three mouse genomic phage clones using an Ipl genomic probe and found that two of these clones hybridized with the Impt1 cDNA. By sequencing the region between Ipl and Impt1 we determined that the distance between the 3′-ends of these genes in the mouse is 2 kb and that, as is true in humans, the genes are oriented tail-to-tail (Fig. 1B) . Thus, consistent with the overall conservation of synteny of the imprinted domain, these two genes have been maintained in a conserved configuration in mammalian evolution.
Tissue-specific expression of mouse and human IMPT1
Northern blots showed that human IMPT1 mRNA is expressed at high levels in many but not all fetal and adult tissues. Tissues with relatively low expression included brain and lung, while tissues with high expression included kidney and liver ( Fig. 2A) . This distribution of expression appears consistent with the predicted role of the IMPT1 protein as a metabolite transporter, since kidney tubular epithelium and liver parenchyma are responsible for active transport of multiple metabolites. As noted above, in addition to the major 1.5 kb mRNA the complex northern band pattern suggested the presence of alternative splicing, alternative transcriptional initiation sites or other forms of alternative transcripts. The simplified band pattern observed with the isolated exon 8 probe supports alternative exon usage in the various transcripts from this locus ( Fig. 2A) . A parallel analysis using the murine Impt1 cDNA probe (Fig. 2B ) gave similar results and also provided additional information. First, mouse Impt1 mRNA was detected at high levels in tissues with metabolite transport functions, such as the extra-embryonic membranes (yolk sac), which have an important role in metabolite exchange in the early embryo, as well as the liver, kidney and intestine. Tissues which lack general transport functions, such as heart, skeletal muscle, brain, thymus and spleen, did not show signals with the mouse probe, although Impt1 mRNA could be amplified from these sources by reverse PCR (below). Second, the northern blot band pattern observed in the murine tissues was considerably simpler than the corresponding human pattern and showed primarily the 1.5 kb band; only the placenta showed an alternative transcript which was slightly smaller than that seen in the other tissues (Fig. 2B) . This supports the likelihood that the major 1.5 kb mRNA is the most physiologically important spliced form of IMPT1 mRNA. Alternative transcripts could, however, be important in particular tissues and could in principal give rise to sequence diversity in the protein, but this remains to be tested.
Imprinting of mouse Impt1
Interspecific mouse crosses have been widely used to study parental imprinting, since these crosses reliably generate heterozygosity for exonic polymorphisms in the F1 progeny. Most recently we used an extensive series of staged interspecific crosses to characterize the imprinting of murine Ipl in fetal and adult tissues (17) . We used cDNA preparations from these same types of crosses to investigate possible imprinting of Impt1. The maternal and paternal alleles in cDNA and genomic PCR products were distinguished by three methods: direct sequencing, RFLP analysis and SSCP analysis. We previously showed that all three methods yield reliable qualitative information concerning allele-specific expression levels and that RFLP and SSCP produce accurate quantitative data (17) . We used precise reciprocal crosses as well as two different types of crosses, involving BL/6 and two different divergent subspecies, Mus mus molossinus (MOLD) and M.m.castaneus (CAST), in order to test the generality of any functional imprinting which might be observed, i.e. to exclude possible strain-specific effects. The results are shown in Figure 4 and Table 1 . A clear and consistent allelic expression bias diagnostic of parental imprinting was detected in fetal tissues of all crosses. Tissues showing very strong functional imprinting (virtually monoallelic expression) included placenta, extra-embryonic membranes (yolk sac) and fetal liver. In these tissues >80% of total expression derived from the maternal allele ( Fig. 4A and Table 1 ). In every cross there was preferential expression of the maternal Impt1 allele (relative paternal repression or 'paternal imprinting') and there was no evidence of somatic allele switching when the direction of bias was compared across multiple organs. In adult tissues the allelic expression bias became less pronounced or disappeared entirely. We conclude that Impt1 is imprinted in the same parental 'direction' as Ipl, Mash2, p57 Kip2 , KvLQT1 and H19 and in the opposite direction to Igf2 and Ins2. The allelic bias was measured by densitometry of RFLP films. Crosses are indicated by the usual convention of (female × male). There is strongly selective expression of the maternal allele in fetal tissues and attenuation of the functional imprint in adult tissues. Values are from single determinations; similar results were obtained in two experiments. For all cases the allelic bias was scored qualitatively by inspection of SSCP and RFLP films and quantitatively by densitometry of the SSCP films, except for case 1863, which was scored by densitometry of RFLP films; where shown, the standard errors are based on three or four determinations with independent cDNA aliquots, other values are from single determinations, but these data were also reproduced in independent cDNA aliquots. A designation of 'no allelic bias' indicates <10% bias on densitometry. The more active allele is indicated for each sample. There is marked interindividual variation in strength of functional imprinting even when the same organs are compared at similar developmental stages.
Variable allelic expression bias of human IMPT1
We screened the human IMPT1 gene for exonic polymorphisms which would allow us to distinguish the two alleles. By SSCP and direct sequencing of genomic and cDNA PCR products we identified four useful polymorphisms, two in exon 2 and two in exon 11, as well as several less common polymorphisms (Materials and Methods and Table 2 ). We then analyzed relative expression levels from the two alleles in autopsy or surgical tissues from four fetuses (16-23 weeks gestation), two newborns, two children and four adults, as well as seven term placentas and corresponding chorioamnionic membranes (Table 2 and Fig. 5A-D) . We used reverse transcription-PCR strategies, which are shown in Figure 1B and which were analogous to those used for analysis of the mouse gene. Genomic PCR reactions were run in each experiment to establish the relative band intensities on the SSCP and RFLP analyses corresponding to equal allelic representation. An allelic expression bias was observed in multiple tissues of several individuals and the experimental data were highly reproducible when multiple aliquots of cDNA were examined ( Fig. 5B and Table 2 ). Some tissues showed a strong allelic bias, with densitometry indicating that >80% of the total cDNA derived from one allele, but other tissues showed little or no allelic expression bias. As shown in Table 2 and Figure 5A -D, certain organs, such as fetal and adult kidney, consistently showed a weak allelic expression bias, while others, such as placenta, chorioamnion, liver and adrenal gland, tended to show a stronger bias, but there were major interindividual variations in the strength or even the presence or absence of an allelic bias, even when identical organs were examined at comparable developmental stages (compare different placentas, chorioamnions, adrenal glands and lungs in Table 2 ). Consistent with genomic imprinting and with our findings in the interspecific mouse crosses, in almost all cases within a single individual all or most of the organs examined showed the same 'direction' of allelic expression bias (Table 2 and Fig. 5A-D) .
Moreover, in one placenta/amnion pair for which parental DNAs were available and informative we found that the expressed allele was maternal, consistent with the direction of imprinting observed in the mouse crosses (Fig. 5A) . However, while 12 cases (including the placenta/amnion pairs) in which two or more tissues showed an allelic expression bias showed a consistent 'direction' of the bias, in one placenta/ chorioamnion pair there was an opposite allelic expression bias in placenta versus chorioamnion (Fig. 5D and Table 2 ). Since the PCR products spanned a region of the IMPT1 gene which contains multiple sequence polymorphisms (D.Dao and B.Tycko, unpublished observations), this case showed a characteristic SSCP band pattern which was shared by the two tissues (albeit with variations in relative band intensities due to the allelic bias) and which therefore provided an internal control to exclude sample identification error as an artifactual explanation for the allele switching. As a further control for sample identification in this case we ascertained the representation of H19 exon 3-5 polymorphisms (7, 18, 24) in the same preparations and the results were consistent in both tissues (homozygosity for the RsaI '+' allele in both genomic samples and exclusive representation of this allele in the cDNAs; Fig. 5D ). In two other cases (adult 861 and fetus 994) there were weaker suggestions of allele switching in certain organs ( Fig. 5A and C and Table 2 ). Somatic allele switching is not a common feature of imprinted genes, but we previously observed this unusual phenomenon for the imprinted human H19 gene in the cerebellum, a site of low H19 RNA expression and unusual H19 CpG methylation, in one adult (24) . Allele switching has recently been suggested for the human WT1 gene, which is functionally imprinted in some tissues (though not in kidney) and which can show either a maternal or a paternal expression bias depending on the tissue source (25) . To our knowledge allele switching has not been reported for any imprinted genes in mice and, consistent with this, we did not observe allele switching at the murine Impt1 locus in any fetal or post-natal tissues (Table 1) .
DISCUSSION
Mouse and human IMPT1 genes and the paternal/maternal competition model for imprinting
Genomic imprinting has persisted in mammalian evolution and so it is suspected to confer some reproductive advantage. According to the influential maternal/paternal competition model (1) imprinting regulates the effective dosage of genes which control fetal and placental growth. Based on the strong functional imprinting (allelic expression bias) of mouse Impt1 in extra-embryonic and some fetal tissues, it is likely that imprinting does regulate the effective dosage of this gene in these tissues. This needs to be tested directly by germline deletion, but it is possible that a metabolite transporter expressed in yolk sac and placenta might indeed play an important role in regulating growth of these tissues and of the embryo proper. At this point it is more difficult to understand the implications of our data in terms of the second prediction of the maternal/paternal competition model, that maternally expressed/paternally repressed ('paternally imprinted') genes should be growth inhibitory and that oppositely imprinted genes should be growth promoting. Why would a metabolite transport protein be expected to function as a growth inhibitor? Germline deletion experiments in mice, genetic characterization of the C53B4.3 C.elegans homolog and biochemical studies may shed light on this. Human IMPT1 maps in the Wilms' tumor-2 (WT2)/Beckwith-Wiedemann syndrome (BWS) region of chromosome 11p15.5. IMPT1 is strongly expressed but not strongly imprinted in kidney. Expression of IMPT1 mRNA does seem to track with the tissues which are most affected by fetal overgrowth in BWS and studies of genetic and epigenetic lesions in this gene in BWS might be of interest. The impetus for these studies would be stronger if genetic and biochemical experiments eventually point to a growth inhibition pathway related to metabolite transport, as would be predicted from our data if the paternal/maternal competition theory is valid. It is interesting that another gene belonging to the polyspecific transporter family and distantly related to Impt1 by sequence similarity has recently been mapped very close to the imprinted Igf2r gene on mouse chromosome 17 (26) . This gene, Lx1, was shown to be biallelically expressed in at least some adult mouse tissues, but functional imprinting of this locus in other tissues has not been excluded.
IMPT1 gene structure and the host defense model for imprinting
The host defense model for imprinting (2-4) posits that imprinted genes resemble integrated retroviruses or retrotransposons and are therefore specifically recognized by DNA methyltransferase enzyme(s) and targeted for inactivation in one of the parental germlines. This model has been supported by a statistical argument showing that among the known imprinted genes there is on average a more compact exon/intron structure than is observed in the genome as a whole (3) and by descriptions of repetitive sequences near imprinted genes (2). Our recent finding that the very compact IPL gene is strongly imprinted in several mouse and human tissues adds incremental support to this theory (17) . The human IMPT1 gene does not appear to be particularly compact, since it includes at least 11 exons spaced over 23 kb of DNA. Additional examples of imprinted genes are needed for a Figure 5 . Allelic expression analysis of human IMPT1. (A) Fetal, newborn and adult organs assessed for allelic expression bias by HinfI RFLP and parallel SSCP analysis of RT-PCR products from IMPT1 exons 2 and 3. (Upper left) Maternal origin of the preferentially expressed allele; the experiments in the left panels used cDNA primers IMPT1-5′-3/IMPT1-3′-5, while those in the right panels used alternative cDNA primers IMPT1-5′-2/IMPT1-3′-2. Allele-specific bands are indicated and only the informative regions of the gels are shown; other bands were present at other positions. Note that the SSCP band patterns differ among the cases, reflecting additional sequence polymorphisms outside the HinfI site. The preferentially expressed allele is indicated and is highlighted in bold for samples with the strongest bias. Similar results were obtained for all samples when the analysis was repeated with independent aliquots of cDNA and, in some cases, with independent cDNA preparations. The slight splitting of the upper SSCP band in the lung of adult 1720 is a gel loading artifact which was not seen in a replication. G, genomic DNA; M, mother; F, father; Pl, placenta; Am, chorioamnion. 
IMPT1 allelic expression and interindividual variation in human imprinting
Interindividual variations in the strength of imprinting (27, 28) might cause phenotypic variations. Such variability within populations could be accounted for either by trans-acting modifiers or by cis-acting variations in gene structure. In view of the major interindividual variations which we have observed in the strength of IMPT1 allelic expression bias, in the future it may be interesting to correlate the strength of imprinting with polymorphisms in IMPT1 gene structure. We have found at least one frequent insertion/deletion polymorphism of an Alu retroelement in IMPT1 intron 8 (D.Dao and B.Tycko, unpublished data) and this type of polymorphism could be informative if analyzed in a large group of cases. In addition, the extended genomic sequence spanning IPL, IMPT1 and other genes (human 244 kb contig from chromosome 11p15.5, HTGS phase 3, complete sequence; GenBank accession no. U90582) indicates that there are several blocks of simple direct repeat sequences both near and within the IMPT1 gene (see Methods section of 17). It is also possible that the more complex pattern of IMPT1 mRNA transcripts in human compared with mouse might account for the greater variability in functional imprinting of the human gene: we do not have data on transcript-specific imprinting of IMPT1, but a precedent for transcript-specific imprinting exists in the human IGF2 locus (29) and, if different individuals express different ratios of imprinted versus non-imprinted transcripts or even oppositely imprinted transcripts, then this could explain the interindividual variability in the observed functional imprinting. The murine Impt1 gene produces a simpler set of transcripts and, while it is difficult to precisely match the mouse and human tissues for developmental stage, the imprinting in mice does appear to be more robust and consistent. It is also possible that neighboring or overlapping transcripts might influence the apparent strength and direction of IMPT1 imprinting and further analysis of the 2G3-8 gene, which produces some transcripts which are partially antisense to IMPT1 (Fig. 1A and unpublished observations) may be relevant. In terms of the most interesting possibility, the existence of modifier genes which affect the strength of imprinting and which act in trans at multiple imprinted loci, the fact that both IMPT1 and IPL (17) , as well as p57 KIP2 (14) and KvLQT1 (15) , show leaky imprinting with interindividual variability suggests that in the future it may be possible to correlate data on the strength of imprinting of genes throughout the domain to ask whether imprinting modifier genes act in humans to produce weak and strong phenotypes for domain-wide imprinting.
Paternal repression of Impt1 and the chromatin accessibility model for imprinted domains
The fact that of the eight genes known to be imprinted in this region at least six are paternally repressed (Fig. 1A) suggests that the primary effect of domain-wide human chromosome 11p15.5/mouse distal chromosome 7 imprinting is repression of the paternal allele relative to the maternal allele. This is consistent with the chromatin accessibility model for imprinting, in which the domain is postulated to correspond to a large region of 'open' and therefore epigenetically modifiable chromatin in pre-meiotic and meiotic sperm progenitors (30, 31) . Recombination frequencies are in fact higher for chromosome 11p15.5 markers in paternal as compared with maternal meioses (31) . If one assumes the opposing model of random imprinting through the domain, then by at least one test the probability of observing six of eight genes paternally repressed is 0.3 (not significant; two-tailed statistical test on proportions). However, since the relative maternal repression of Igf2 and Ins2 may reflect a secondary phenomenon resulting from enhancer competition with the paternally repressed H19 gene, as suggested by findings in human Wilms' tumors (32) (33) (34) and more definitively by mouse knockout data (35) , the simplest explanation of the data is that all of the genes in this region which are the targets of primary imprinting are paternally repressed. Given a model of random imprinting, the probability of observing six of six genes imprinted in the same direction is 0.016, so there is strong statistical support for non-random domain-wide relative paternal repression. Moreover, our preliminary data indicate that a seventh gene in the region, Tapa1, is subject to leaky imprinting with relative repression of the paternal allele in the extra-embryonic tissues (L.Yuan, C.Walsh and B.Tycko, in preparation). Given the very dense clustering of imprinted genes which is highlighted by this and previous reports, a direct analysis of chromatin structure throughout the known extent of the domain in spermatocytes, together with additional annotation of imprinting in the region, should be able to test differential chromatin accessibility as the mechanism dictating the locations and extents of imprinted domains. This model does not make a prediction as to the specific type of epigenetic modification which confers and maintains the regional imprint. DNA methylation has been a strong candidate (reviewed in 36) and this type of local modification plays an essential role in maintaining and possibly initiating imprinting of some strongly repressed loci, but extensive CpG methylation is not present in all imprinted genes (14, 37) and the strongly imprinted human and mouse H19 genes, which have been used as models systems for imprinting, are unusually extensively methylated (24, (32) (33) (34) 38) and may be unusually sensitive to reactivation by demethylation (14, 39) . For the extended imprinted domain there are as yet few data implicating DNA methylation as a maintenance mechanism. Other factors which can regulate chromatin structure and also propagate epigenetic states, such as templating by histone acetylation patterns and repressive chromatin proteins (40, 41) , deserve more attention.
MATERIALS AND METHODS
Genomic clones and exon trapping
The human P1 clones shown in Figure 1A were described in our previous report (17) . Exon trapping of clone 12766 used the pSPL3 vector (Exon Trapping System, Life Technologies, Gaithersburg, MD). Mouse genomic clones, including λIpl-1, containing Ipl and the 3′-portion of Impt1, were isolated from a strain 129/Sv λ library as described previously (17) .
cDNAs, sequences and accession numbers
To obtain the human IMPT1 cDNA sequence we used a combined strategy of EST database searches, complete sequencing of a 1.5 kb cDNA isolated from a placental cDNA λgt11 library (1G2-5 clone 8) and partial sequencing of a second 1.4 kb cDNA (1G2-5 clone 11) from this same library. The murine Impt1 cDNA sequence was obtained by re-sequencing two EST-derived overlapping cDNA clones (clone accession nos. W71351 and AA122896). The results were confirmed by generating a 1143 bp RT-PCR product spanning the second to the last exon from mouse liver RNA. The genomic sequence between the 3′-ends of the mouse Impt1 and Ipl genes was obtained from a plasmid subclone of λIpl-1. The genomic structure of human IMPT1 was deduced by screening the IMPT1 cDNA, sequencing against the extended genomic sequence in the nr database (human 244 kb contig from chromosome 11p15.5, HTGS phase 3, complete sequence; accession no. U90582). The human and mouse Impt1 cDNA sequences have accession nos. AF028738 and AF028739.
Northern blotting
RNA was prepared from mouse tissues using Trizol reagent (Life Technologies). Northern blots containing poly(A) + RNA from adult mouse and fetal and adult human tissues were from a commercial source (Clontech, Palo Alto, CA). Blots containing total RNA from mouse tissues were from formaldehyde-containing 1% agarose gels which contained 8 µg RNA/lane.
PCR, SSCP and direct sequencing
Reverse transcription of total RNA was done with the Superscript Preamplification System (Life Technologies), direct sequencing of PCR products and cDNA and genomic clones was done with the fmol Cycle Sequencing System (Promega, Madison, WI) and SSCP analyses were carried out as previously described (46) , but the gels were run at room temperature (500 V, 10-16 h) and the gels for analysis of mouse Impt1 included 6% glycerol. In some cases the radiolabeled PCR products were digested with restriction enzymes prior to SSCP analysis to generate comparably sized genomic and cDNA fragments (see below). PCR amplification of genomic DNA and cDNAs was with standard Taq polymerase (BoehringerMannheim) using standard buffer supplied by the manufacturer, with addition of DMSO to 5%. Primers for human IMPT1 had the sequences: IMPT1-5′-2 (exon 1), TCACCCCACCGGCACCCGT; IMPT1-5′-3 (exon 2), AGGCGGGTGCTGCCTGGGA; IMPT1-3′-2 (exon 4), CCCCGCGCTGGTCTGCGAAC; IMPT1-3′-5 (exon 3), GGCCCGCCCAGCAGCTGCA; IMPT1-3′-11 (exon 2), CACGATGGAGAACTGCAT; IMPT1-5′-7 (exon 10), GGCTGTCTCCACCTCGGAC; IMPT1-3′-8 (exon 11), TCTTTATTGCCAGTCTGTG; IMPT1-1G2-5gen (exon 11), GGCCTCTGCGCCTCTGTA Analogous to strategies which we used previously for analysis of other imprinted genes (7, 14, 17) , the PCR schemes were such that the cDNA products, made with IMPT1-5′-2/IMPT1-3′2 or alternatively with IMPT1-5′-3/IMPT1-3′-5 or IMPT1-5′-7/ IMPT1-3′-8, each spanned an exon/exon junction, while the genomic products, made with IMPT1-5′-3/IMPT1-3′-11 or IMPT1-1G2-5gen/IMPT1-3′-11, were within single exons. Primers for murine Impt1 cDNAs had the following sequences. For crosses between BL/6 and CAST: Impt1-5′-1 (exon 2), ATCAACAGGACTTTTGCCCC, and Impt1-3′-6 (exon 3), ACAGAATCTAGGCCCAGTG, or alternatively Impt1-3′-1 (exon 4), GCCCGCCAGGAAGGAGAG. For crosses between BL/6 and MOLD: Impt1-5′-6 (exon 2), TGTCTGCCTGGGAT-GTCTG, and Impt1-3′-1. For genomic PCR in crosses between BL/6 and either CAST or MOLD: Impt1-5′-1 (exon 2) and Impt1-3′-5 (exon 2), CATGAAGAGACACGTTAGC.
PCR conditions for human IMPT1 cDNAs and genomic DNA were an initial denaturation at 94_C for 5 min, followed by 35 cycles of denaturation at 94_C for 45 s, annealing at 62_C for 30 s and extension at 72_C for 60 s, with a final extension at 72_C for 7 min. PCR conditions for murine Impt1 cDNAs and genomic DNA were an initial denaturation at 95_C for 3 min, followed by 95_C for 30 s, 60_C for 30 s and 68_C for 1 min for 35 cycles, with a final extension at 68_C for 7 min. Radiolabeling was by PCR for an additional eight cycles after dilution of the gel-isolated primary product 1:10 into complete PCR mixture with addition of [ 32 P]dCTP. For RFLP analysis of human IMPT1 allelic expression PCR products were digested with HinfI, AvaII or HpaII. For RFLP analysis of mouse Impt1 allelic expression PCR products were digested with either HpaII (crosses with MOLD) or KspI (crosses with CAST). Digested products were electrophoresed on 12% (w/w) non-denaturing acrylamide gels. For SSCP analysis of human IMPT1 the labeled PCR products were digested with HpaII (exon 2-3 products) or CfoI (exon 10-11 products) to generate fragments of equal lengths in the cDNA and genomic lanes.
Exonic polymorphisms and assessment of allelic expression
Polymorphisms in mouse Impt1 were (relative to the domesticus strain cDNA sequence): CAST, c108→t (deleting a KspI site); MOLD, c194→a (deleting an HpaII site). Polymorphisms in human IMPT1 were: g210→a (creating an HinfI site); g259→a (deleting an HpaII/AvaII site); c1382→t (creating a variant SSCP pattern); g1448→a (creating a variant SSCP pattern). Several other human polymorphisms were found, but these were not used in the current study. Where indicated, allelic expression bias was measured by densitometry of the allele-specific bands in lightly exposed RFLP or SSCP films with a flatbed scanner (SuperVISTA S-12, UMAX) using NIH Image v.1.49 software. Mixing experiments used defined amounts of gel-isolated cDNA PCR products as templates. As a second control, genomic DNA PCR products were included and the ratios of the allele-specific band intensities were taken as 50:50 allelic representation. Where possible, SSCP results were validated by parallel RFLP analysis of the same radiolabeled products. For mouse Impt1 the RFLP results were validated qualitatively by direct sequencing of the same templates.
